Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease

Clinical trial NCT06902428 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06902428
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet's Disease

Start date: 2025-03-24
Primary completion: 2026-06-05
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.